In March 2016, the FDA approved a new medication called ixekizumab (under the brand name Taltz) for the treatment of psoriatic arthritis and moderate-to-severe cases of plaque psoriasis. Ixekizumab is…
Category
In March 2016, the FDA approved a new medication called ixekizumab (under the brand name Taltz) for the treatment of psoriatic arthritis and moderate-to-severe cases of plaque psoriasis. Ixekizumab is…